ASRS
AXSM icon

Arizona State Retirement System’s Axsome Therapeutics AXSM Stock Holding History

Arizona State Retirement System’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Sell
9,595
-192
-2% -$33.2K 0.01% 840
2025
Q4 		$1.79M Sell
9,787
-409
-4% -$57.1K 0.01% 811
2025
Q3 		$1.24M Buy
10,196
+258
+3% +$29.1K 0.01% 1031
2025
Q2 		$1.04M Buy
9,938
+917
+10% +$97.1K 0.01% 1079
2025
Q1 		$1.05M Sell
9,021
-33
-0.4% -$3.76K 0.01% 1032
2024
Q4 		$766K Buy
9,054
+164
+2% +$15.1K ﹤0.01% 1264
2024
Q3 		$799K Buy
8,890
+260
+3% +$22.7K 0.01% 1233
2024
Q2 		$695K Buy
8,630
+177
+2% +$13.1K ﹤0.01% 1252
2024
Q1 		$675K Sell
8,453
-122
-1% -$10.2K ﹤0.01% 1270
2023
Q4 		$682K Sell
8,575
-708
-8% -$47.3K 0.01% 1273
2023
Q3 		$649K Sell
9,283
-495
-5% -$37K 0.01% 1231
2023
Q2 		$703K Buy
9,778
+341
+4% +$25.2K 0.01% 1226
2023
Q1 		$582K Buy
9,437
+908
+11% +$59.7K 0.01% 1323
2022
Q4 		$658K Buy
8,529
+598
+8% +$35.7K 0.01% 1219
2022
Q3 		$354K Buy
7,931
+270
+4% +$13.5K ﹤0.01% 1528
2022
Q2 		$293K Buy
7,661
+1,038
+16% +$32.8K ﹤0.01% 1687
2022
Q1 		$274K Buy
6,623
+31
+0.5% +$961 ﹤0.01% 1847
2021
Q4 		$249K Sell
6,592
-60
-0.9% -$2.21K ﹤0.01% 1950
2021
Q3 		$219K Buy
6,652
+54
+0.8% +$2.1K ﹤0.01% 2028
2021
Q2 		$445K Sell
6,598
-1,555
-19% -$93.3K ﹤0.01% 1645
2021
Q1 		$462K Buy
8,153
+44
+0.5% +$3.1K ﹤0.01% 1582
2020
Q4 		$661K Sell
8,109
-282
-3% -$21.1K 0.01% 1310
2020
Q3 		$598K Buy
8,391
+2,139
+34% +$167K 0.01% 1201
2020
Q2 		$514K Buy
6,252
+581
+10% +$44.7K 0.01% 1114
2020
Q1 		$334K Buy
+5,671
New +$462K 0.01% 1219

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arizona State Retirement System's AXSM Position: Q1 2026 in Review

Arizona State Retirement System reduced its Axsome Therapeutics (AXSM) stake by 2% in Q1 2026, selling an estimated $33.2K and leaving 9,595 shares worth $1.62M. The position accounts for 0.01% of the portfolio, ranked #840.

Arizona State Retirement System first reported a position in AXSM in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.79M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Arizona State Retirement System held 9,595 shares of Axsome Therapeutics worth $1.62M as of Q1 2026.
  • Arizona State Retirement System sold 192 Axsome Therapeutics shares in Q1 2026, an estimated $33.2K.
  • Axsome Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #840 holding.
  • Arizona State Retirement System first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Arizona State Retirement System's Axsome Therapeutics position peaked at $1.79M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.